Edition:
United States

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

0.75USD
3:33pm EDT
Change (% chg)

$0.00 (+0.35%)
Prev Close
$0.75
Open
$0.74
Day's High
$0.76
Day's Low
$0.74
Volume
21,271
Avg. Vol
226,478
52-wk High
$5.28
52-wk Low
$0.51

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.08 December 26 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 3 4
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 4 0.00 0.00 0.00 6.03
Quarter Ending Dec-16 4 0.00 0.00 0.00 24.11
Year Ending Dec-16 4 0.00 0.00 0.00 16.69
Year Ending Dec-17 4 0.00 0.00 0.00 55.32
Earnings (per share)
Quarter Ending Sep-16 4 -0.08 -0.06 -0.09 -0.06
Quarter Ending Dec-16 4 -0.08 -0.06 -0.09 0.10
Year Ending Dec-16 4 -0.29 -0.26 -0.34 -0.26
Year Ending Dec-17 4 -0.31 -0.20 -0.40 0.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 0.00 0.00 0.00 0.00
Quarter Ending Dec-15 0.00 0.00 0.00 0.00
Quarter Ending Sep-15 0.00 0.00 0.00 0.00
Quarter Ending Jun-15 0.00 0.00 0.00 0.00
Quarter Ending Mar-15 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-16 -0.07 -0.07 0.00 -4.95
Quarter Ending Dec-15 -0.07 -0.07 0.00 -3.70
Quarter Ending Sep-15 -0.07 -0.05 0.02 -25.93
Quarter Ending Jun-15 -0.08 -0.06 0.02 -25.00
Quarter Ending Mar-15 -0.09 -0.06 0.03 -33.33

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 0.00 0.00 0.00 0.00 6.03
Quarter Ending Dec-16 0.00 0.00 0.00 0.00 24.11
Year Ending Dec-16 0.00 0.00 0.00 0.00 16.69
Year Ending Dec-17 0.00 0.00 0.00 0.00 55.32
Earnings (per share)
Quarter Ending Sep-16 -0.08 -0.08 -0.08 -0.07 -0.06
Quarter Ending Dec-16 -0.08 -0.08 -0.08 -0.07 0.10
Year Ending Dec-16 -0.29 -0.29 -0.29 -0.28 -0.26
Year Ending Dec-17 -0.31 -0.31 -0.31 -0.27 0.07

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.